Form 4 · Filed Jun 2, 2026, 10:46 PM UTC
NBP/NovaBridge Biosciences
Xu Cong Claire — SVP, Clinical Development
AI Thesis
A thesis has not been generated for this filing yet — usually available within 60 seconds of EDGAR publication. Refresh shortly.
Research signal, not investment advice. Form 4 AI surfaces SEC filings and applies an analytical layer — it does not predict prices or recommend trades. Past performance does not guarantee future results. See methodology and public track record for how scores are computed.
Transactions
3 rows| Date | Code | Direction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| Jun 1, 2026 | S | sell | 3,494 | $4 | $13,766 | 290,154 |
| May 30, 2026 | M | other | 9,382 | — | — | 293,648 |
| May 30, 2026 | M | other | 4,079 | — | — | 32,637 |
Source: SEC EDGAR raw filing ↗ · Accession 0002114309-26-000003